Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

2nd Year - Systems 3 > Neuro 5 - dementia and coma > Flashcards

Neuro 5 - dementia and coma Flashcards

1
Q

Types of mood disorder

A

Depression - monopolar
Mania - monopolar
Manic depression - bipolar - treated well with mood stablisers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Depression

A

Emotional symptoms - mood + thought disorder
Biological symptoms - anhedonia, motivational impairment
Cognitive symptoms - difficulty decision making, poor concentration
Psychotic symptoms

  • treatment focuses mainly on improving mood and motivational impairments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mania + bipolar disorder

A
  • need less sleep
  • excessive exuberance, enthusiasm, confidence, grandiosity
  • increased libido
  • behaviours inappropriate to circumstances
  • disorders of thought (psychosis)

May need different drugs for both manic and depressive episodes (and psychosis)
Also preventative medication, mood stabilisers (lithium, anti-epileptic drugs, atypical antipsychotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of depression

A

CHEMICAL IMBALANCE - monoamine theory, well supported BUT delayed onset action antidepressants?
- functional deficit in 5-HT (serotonin) and/or noradrenaline/dopamine

NEURODEGENERATION
- neural apoptosis and neurogenesis

IMMUNE RESPONSE
- sickness behaviour

GENES

ENVIRONMENT (stress)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Treatments for depression

A

Pharmacological
- enhance monoamine levels in CNS - monoamine reuptake inhibitors/monoamine oxidase inhibitors/pre-synaptic receptor antagonists
- specific receptor agonists or antagonists
(consider side effects! if therapy possible, do that)

Cognitive behavioural therapy (mild-moderate depression)

Neurological interventions (30% unresponsive to drugs)

  • electroconvulsive shock therapy
  • deep brain stimulation
  • vagal nerve stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Typical antidepressants

A

(TCAs and specific reuptake inhibitors)

  • monoamine oxidase inhibitors (MAOI)
  • tricyclic antidepressants
  • SSRIs (selective serotonin reuptake inhibitors)
  • selective noradrenaline reuptake inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Monoamine oxidase inhibitors

A

MAOIs
eg IPRONIAZID, PHENELZINE, TRANYLCYPROMINE, MOCLOBEMIDE
- inhibits breakdown of monoamines (MAO found in all tissues inc GI tract)
Multiple side effects - ‘cheese reaction’, need low tyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tricyclic antidepressants

A

eg AMITRIPTYLINE, DESIPRAMINE, CLOMIPRAMINE

  • block reuptake of monoamines (mainly NA and 5-HT)
  • many have active metabolites, issues
  • multiple side effects
  • cardiotoxicity, low therapeutic index!

Used less in depression now, often for pain management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Selective reuptake inhibitors

A

SSRIs - FLUOXETINE (= prozac)
+ SNRIs - REBOXETINE
- block reuptake of 5-HT/NA
- similar efficacy and time-course to TCAs
- lack cholinergic side effects - less weight gain, low toxicity in overdose, no food interaction, reduced drug interactions

BUT - still many side effects , specific to serotonin or noradrenaline related effects

Discontinuation syndrome esp in paroxetine, need to be weaned off gradually 6-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atypical antidepressants

A

Mixed action

VENLAFAXINE - SSRI at low doses, SNRI at higher
TRAZEDONE - SSRI + 5-HT2 antagonist
NEFAZODONE - SSRI + 5-HT2 antagonist
MIRTAZAPINE - NA and 5-HT antagonist
AGOMELATINE - melatonin agonist and 5-HT2 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Delayed onset of clinical efficacy of antidepressants

A

Increased synaptic monoamine concentration

  • > activation of somatodendritic autoreceptors - hippocampal neurogenesis
  • > receptor adaptation (plasticity) -> increased synaptic concentration - cognitive effects
  • > activation of pre-synaptic autoreceptors -> decreased neurotransmitter release - post-synaptic receptor adaptation

DON’T KNOW WHY, these are theories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alternative applications for antidepressants

A

SSRIs
- all anxiety disorders - OCD, panic disorder, social phobia, anxiety disorders (esp depression associated), eating disorders

TCAs
- analgesia, migraine prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mood stabilising drugs

A

Lithium

  • mechanism unsure
  • effective in controlling mania
  • potential toxicity, carefully monitor

+ anticonvulsants - valproic acid, carbamezapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dementia definition

A
  • structurally caused
  • permanent or progressive
  • decline in several dimensions of intellectual function
  • interferes substantially with normal social or economical activity

May be static (often following single major injury) or progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of dementia

A

Degenerative - Alzheimer’s, Parkinson’s, Huntingdon’s, MS, MND, Lewy body dementia etc

Vascular - multi-infarct dementia etc

Metabolic/endocrine - hypothyroidism, B12 deficiency

Infective - AIDS-dementia complex, Creutzfeld-Jacob disease etc

Post-neurological insult - open/closed head injury, anoxia, subarachnoid haemorrhage, CO poisoning

Toxic - alcohol, heavy metal, organic solvents

Space occupying lesion - chronic subdural haemorrhage, primary/secondary metastatic intracranial tumour

Other - normal pressure hydrocephalus, epilepsy, systemic lupus etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cortical vs subcortical dementia

A

SUBCORTICAL

  • mild-moderate severity
  • slow cognition
  • memory impairment
  • apathy, depression
  • extrapyramidal motor abnormalities
  • changes to striatum and thalamus

CORTICAL

  • more severe sooner
  • normal speed of cognition, but with frequent errors
  • more severe memory impairment, dysphasia, dyspraxia, agnosia
  • depression rarer
  • uncommon motor abnormalities
  • changes to cortical association areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features of Alzheimer’s disease

A

Neurodegeneration -> loss of cognitive function
4th leading cause of death in elderly, 30% of over 80year olds have

Post mortem shows
- general brain atrophy - shrinkage of cortex, narrowed gyri, widened sulcal margins
- extracellular plaques of β-amyloid (knotted shape)
- intracellular neurofibrillary tangles of tau protein as hyperphosphorylated by overactive kinases (teardrop shape)
(can only be diagnosed definitively on autopsy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Symptoms of Alzheimer’s disease

A

MILD

  • confusion, memory loss
  • disorientation
  • problems with routine tasks
  • changes in personality and judgement

MODERATE

  • difficulty with ADL
  • anxiety, depression, paranoia, aggression, agitation, hallucinations
  • sleep disturbances
  • wandering, pacing
  • difficulty recognising family and friends

SEVERE

  • aphasia (understanding language)
  • apraxia (carrying out tasks)
  • agnosia (recognising things)
  • loss of speech
  • loss of appetite
  • loss of bladder and bowel control
  • > total dependence on caregiver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Amyloid-β plaques

A

In Alzheimer’s disease

  • amyloid precursor protein (APP) is cleaved by proteases, secretase alpha, beta and gamma
  • secretase alpha -> sAPP (secreted, good for cell, harmless growth factor)
  • secretase beta and gamma together -> Aβ protein, takes essential intracelullar part of APP
  • so altered balance between these enzymes -> amyloiogenesis

Aβ then aggregates, body can’t clear, forms amyloid plaques -> neuronal death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risk factors for Alzheimer’s disease

A

Age - risk doubles each 10 years after 65
Family history - genes with mutations in APP?

+ possibles:

  • early traumatic head injury
  • female
  • lower educational level
  • high calorie/fat/cholesterol diet, low exercise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Creutzfeld-Jacob disease

A

CJD

  • fatal, rapidly progressive dementia, loss of motor coordination
  • survival 6 months average
  • no clear gross pathological features
  • can be nvCJD, from contact with BSE infected beef, then long incubation period, forms abnormal form of prion protein, converts other proteins around it to this, aggregates
  • or spontaneous conformational change
22
Q

Currently licensed drug therapy for Alzheimer’s

A

Cholinesterase inhibitors - increase ACh levels (cholinergic cells die early, attempt to compensate)
eg DONEPEZIL, GALANTAMINE, RIVASTIGMINE

Partial NMDA receptor antagonists - neuroprotective, reduce excitability
eg MEMANTINE

(no new licensed drug for 15 years)

23
Q

Potential targets for treatment of Alzheimer’s

A

MODIFY Aβ PATHWAY

  • alpha/beta/gamma secretase inhibitors? to reduce Aβ formation
  • anti-aggregation agents? uses copper + zinc (highly charged) to pull other proteins in - effective but no cognitive effect
  • statins? link between high cholesterol and APP changes
  • enhance Aβ clearance? with immune therapy

MODIFY TAU PATHWAY (some dementias have only tau changes)

  • lithium?
  • microtubule modifiers?
  • tau aggregation inhibitors?
24
Q

Deontology

A

Do your duty
- do not kill/lie/break confidences etc

(may create a corresponding right - right for patient to have doctor fulfil duty)

25
Q

Consequentialism

A

Do that which has the best outcomes
- greatest good for the greatest number

= utilitarianism

26
Q

Virtue ethics

A

Be virtuous

- person based, what would a virtuous person do?

27
Q

Four ethical principles

A

Respect for autonomy - consent, self-rule
Beneficence - provide benefit
Non-maleficence - do no harm
Justice - share resources fairly

(Beauchamp and Childress)

28
Q

Coma

A

Absent wakefulness, absent awareness

  • lasts more than 6 hours
  • cannot be awakened
  • fails to respond normally to painful stimuli, light, sound
  • lacks normal sleep-wake cycle
  • does not initiate voluntary actions
29
Q

Vegetative state

A

Wakefulness, absent awareness

  • preserved capacity for spontaneous or stimulus-induced arousal
  • sleep-wake cycles present
  • reflexive and spontaneous behaviours
  • complete absence of behavioural evidence for self or environmental awareness
Continuing = 4 weeks +
Permanent = 6/12 months +

= post-coma unresponsiveness?
= unresponsive wakefulness syndrome?
Better terminology

30
Q

Advanced directives

A

Must not treat if competent adult refuses
- or is assault/battery/trespass to patient

NEEDS
- competence
and
- current refusal
or
- advance refusal (currently no capacity, but previous specific, written, witnessed refusal of life-support)

May not treat even if competent adult demands - right to refuse but not insist on treatment

31
Q

Minimally conscious state

A

Wakefulness, minimal awareness

  • severely altered consciousness
  • minimal (but clearly discernible) behavioural evidence of self or environmental awareness demonstrated
  • inconsistent but reproducible responses above the level of spontaneous or reflexive behaviour
  • some degree of interaction with surroundings
32
Q

Locked-in syndrome

A

Wakefulness, awareness (paralysed but conscious)

  • loss of all brainstem functions
  • absence of brainstem reflexes - pupillary, corneal, oculovestibular, cough
  • no spontaneous respiratory effort
  • will cease to maintain physiological function without ventilator support
    (may be kept on life-support to allow best interests decision-making (and organ donation))
33
Q

Human tissue act 2004

A
  • appropriate consent needed
  • for storage and use
  • of whole bodies, removal, storage and use of human material (organs, tissues, cells)
  • from deceased and living persons

Consent given from
- person (before death), eg organ donation, donate body to science
- nominated representative, chosen by person before death
- someone in qualifying relationship - spouse, parent/child, sibling, grandparent ect down list
(though need general consensus)

Act doesn’t include hair, nails (cells outside body), non-identifiable DNA analysis, storage and use for research, existing collections

34
Q

Delirium vs dementia

A

DELIRIUM

  • abrupt onset
  • fluctuating course
  • lasts hours-weeks
  • abnormal alertness (high or low)
  • disrupted sleep-wake cycle
  • impaired attention
  • delusional thought
  • incoherent speech
  • hallucinations and illusions

DEMENTIA

  • insidious onset
  • slow-progression
  • lasts months-years
  • normal alertness
  • normal sleep-wake cycle
  • relatively normal attention
  • impoverished thought
  • word-finding difficulty in speech
  • intact perception early on
35
Q

Neuropathology principles in dementia

A

Distribution of abnormalities -> clinical manifestations

Dementias caused by abnormal accumulation of particular proteins/peptides

Distribution of pathophysiological abnormalities generally correlates with distribution of histopathological abnormalities

Same pathophysiological abnormalities can -> different clinical manifestations

Different pathophysiological abnormalities -> same clinical manifestations

Different types of dementia often co-exist

36
Q

Distribution of abnormalities in dementia

A

Temporoparietal -> memory impairment, dysphasia, dyspraxia
Frontotemporal -> behavioural disturbances, personality change, language dysfunction
Subcortical -> slowing of thought processes, motor disturbances

37
Q

Abnormal accumulation of particular proteins/peptides in dementia

A

Alzheimer’s - Aβ plaques and hyperphosphorylated tau
Frontotemporal dementia - FTLD-Tau - 3R, 4R or 3R + 4R
Parkinson’s disease, Lewy body dementia - Lewy bodies, diffuse plaques

(exception is vascular dementia - no accumulation of peptides, mainly in white matter, microinfarcts)
- atheroma and small vessel disease cause

38
Q

Reticular formation

A

Set of interconnected nuclei located throughout brainstem
Includes grey matter immediately below 4th ventricle and around cerebral aqueduct (= periaqueductal grey), and monoamine cell groups
+ non specific nuclei of thalamus, sometimes also hypothalamus considered
Extends caudally into spinal cord

39
Q

Local projections in reticular formation

A

Local-circuit interneurones

Functions - reflexive and stereotyped behaviours involving face and head:
> chewing, swallowing, vomiting
> respiratory activities - cough, sneeze, hiccups
> cardiovascular responses

40
Q

Reticular formation ascending information to cortex

A

(reticular activating system)

Functions:

  • sleep-wake cycle
  • mediates various levels of alertness and consciousness
  • wakefulness (in mid-line group of thalamus)
  • filters incoming stimuli to discriminate irrelevant background stimuli
41
Q

Reticular formation descending information from spinal cord

A

Info from:

  • posture, equilibrium, autonomic nervous system activity
  • sensory (pain) and motor modulation

Also receives information from hypothalamus

42
Q

Overall functions of reticular formation

A

SENSORY AND MOTOR FUNCTIONS

  • gating + modulating info transfer
  • organising, co-ordinating reflexes

AUTONOMIC AND VITAL FUNCTIONS

  • regulates autonomic nervous system
  • cardiovascular regulation
  • control of respiration

ENERGISING/REGULATING FUNCTIONS

  • attention
  • alertness and sleep
  • motivation
  • general excitability in CNS (not specific targets, connections to whole cortex)
43
Q

Neurotransmitter pathways and functions in reticular formation

A

NORADRENALINE
From lateral tegmental system - to basal ganglia
- autonomic, endocrine, appetite functions
From locus ceruleus system - links all over cortex and cerebellum, so can synchronise brain regions
- alertness, attention

5-HT, SEROTONIN
From Raphe nucleus - to cerebellum and all over cerebral cortex
- sleep, mood/motivation, autonomic NS, pain transmission

ADRENALINE
To hypothalamus
- cardiovascular function

DOPAMINE
From substantia nigra to basal ganglia, and from ventral tegmental area to limbic areas and cortex
- drive/motivation, pleasure
(affected in schizophrenia, addiction)

ACETYLCHOLINE
From basal forebrain nucleus and septal nuclei to all cortex, and from septal nuclei to hippocampus
- alertness/sleep, memory and learning

44
Q

Cardiovascular control in reticular formation

A

(in medullary and lower pontine RF)

INPUTS

  • baro-/chemoreceptors of aortic arch (via vagus) and carotid sinus (via glossopharyngeal)
  • autonomic activity from spinal cord
  • autonomic reflex afferents from vagus
  • blood and CSF composition from area postrema

OUTPUTS

  • dorsal motor nucleus of vagus
  • sympathetic outflow in intermediolateral column in cord
45
Q

Ventilatory control in reticular formation

A

MEDULLA

  • ventral respiratory group - voluntary forced exhalation, and to increase force inspiration
  • dorsal respiratory group - most inspiratory movements and timing

PONS

  • pneumotaxic centre - coordinates inhale-exhale transition, inhibits inhalation, fine tunes respiration rate
  • apneustic centre - coordinates inhale-exhale transition, stimulates inhalation (overridden by pneumotaxic control to end inspiration)
46
Q

Brainstem lesions and effects on respiratory system

A

i) Diffuse forebrain depression -> waxing/waning respiration pattern, periods of apnea, Cheyne-Stokes respiration
ii) Midbrain damage -> hyperventilation
iii) Rostral pons damage -> apneusis, briefly halts breathing at full inspiration
iv) Lower pons or upper medulla damage -> irregular/uneven depth respiration, ataxic breathing
Often -> respiratory arrest

47
Q

Glasgow coma scale

A

= GCS, coma is score less than 8

Eye opening (E)
4 = spontaneous
3 = to voice
2 = to pain
1 = absent
Vocal response (V)
5 = normal conversation
4 = disoriented
3 = incoherent words
2 = incomprehensible sounds
1 = absent
Motor response (M)
6 = normal
5 = localised response to pain
4 = withdrawal from pain
3 = rigidity with limb flexion 
2 = rigidity with limb extension 
1 = absent
48
Q

Sleep

A

Light - easily awakened
Deep - needs strong sensory stimulus for arousal
REM - 5-30min periods every 90 mins, deep sleep, cerebral cortex very active, dreaming, muscular relaxation

  • > decreased plasma volume
  • > decreased HR
  • > decreased bp
  • > decreased rate and force of respiration
  • > decreased salivary and lacrimal secretion
  • > decreased formation of urine
  • > increased sweat secretion
  • > decreased muscle tone and reflexes (except ocular muscles)
49
Q

EEG

A

= electroencephalogram
- shows changes in level of consciousness, activity in cerebral cortex

Fully alert - low voltage, high frequency
Deep sleep - taller, longer waves
REM sleep - desynchronised
Comatose - reduced voltage and frequency
Cerebral cortex death - flat EEG
50
Q

Types of sleep disorder

A

Insomnia - difficulty falling/staying asleep
Hypersomnia - excessively sleepy
Narcolepsy/cataplexy - excessively sleepy, daytime sleep attacks
Sleep apnea - pauses or low frequency breathing during sleep
Night terror - extreme terror, temporary inability to regain full consciousness
Somnambulism - sleep walking
Nocturnal enuresis - bed wetting
Movement disorders

2nd Year - Systems 3 (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions